Sol-Gel Technologies (SLGL) Accounts Payables (2016 - 2026)
Sol-Gel Technologies (SLGL) reported Accounts Payables of $782000.0 for Q1 2026, up 78.54% year-over-year from $438000.0 in Q1 2025, and up 6.39% quarter-over-quarter from $735000.0 in Q4 2025.
Sol-Gel Technologies (SLGL) Accounts Payables (2016 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has 11 years of Accounts Payables data on file, last reported at $782000.0 in Q1 2026.
- Accounts Payables for Q1 2026 came in at $782000.0, up 78.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $782000.0 (up 78.54% YoY), and the FY2025 annual result was $735000.0, down 79.53% from the prior year.
- Accounts Payables improved to $782000.0 in Q1 2026 per SLGL's latest filing, from $735000.0 in the prior quarter.
- Over five years, Accounts Payables peaked at $3.6 million in Q4 2024 and troughed at $154000.0 in Q4 2023.
- A 5-year average of $817294.1 and a median of $679000.0 in 2024 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2022 and 2024: Accounts Payables plunged 87.06% in 2022, then jumped 2231.17% in 2024.
- A 5-year view of Accounts Payables shows it stood at $251000.0 in 2022, then slumped by 38.65% to $154000.0 in 2023, then jumped by 2231.17% to $3.6 million in 2024, then plunged by 79.53% to $735000.0 in 2025, then increased by 6.39% to $782000.0 in 2026.
- Business Quant data shows SLGL's Accounts Payables at $782000.0 in Q1 2026, $735000.0 in Q4 2025, and $828000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.64 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Sol-Gel Technologies | 207.80 Mn | 197.67 Mn | - | 782,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 782,000.00 |
| Dec 31, 2025 | 735,000.00 |
| Sep 30, 2025 | 828,000.00 |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | 438,000.00 |
| Dec 31, 2024 | 3.59 Mn |
| Sep 30, 2024 | 1.52 Mn |
| Jun 30, 2024 | 679,000.00 |
| Mar 31, 2024 | 582,000.00 |
| Dec 31, 2023 | 154,000.00 |
| Sep 30, 2023 | 234,000.00 |
| Jun 30, 2023 | 461,000.00 |
| Mar 31, 2023 | 339,000.00 |
| Dec 31, 2022 | 251,000.00 |
| Sep 30, 2022 | 167,000.00 |
| Jun 30, 2022 | 860,000.00 |
| Mar 31, 2022 | 1.11 Mn |
| Dec 31, 2021 | 766,000.00 |
| Sep 30, 2021 | 1.29 Mn |
| Jun 30, 2021 | 1.35 Mn |